This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mielcarek, N. Articles by Riveau, G. Search for Related Content PubMed PubMed Citation Articles by Mielcarek, N. Articles by Riveau, G.

 Previous Article  |  Next Article 

Infect. Immun., 02 1997, 544-550, Vol 65, No. 2
Copyright © 1997, American Society for Microbiology

Intranasal priming with recombinant Bordetella pertussis for the induction of a systemic immune response against a heterologous antigen

N Mielcarek, J Cornette, AM Schacht, RJ Pierce, C Locht, A Capron and G Riveau
Laboratoire des Relations Hotes-Parasite et Strategies Vaccinales, INSERM U167, Institut Pasteur de Lille, France.

One of the current goals in vaccine development is the noninvasive administration of protective antigens via mucosal surfaces. In this context, the gut-associated lymphoid tissues have already been extensively explored. Vaccination via the nasal route has only recently been the focus of intensive investigation, and no live vector specifically designed for the respiratory mucosa is yet available. In this study we show that intranasal administration of the recombinant Bordetella pertussis BPGR60, producing the Schistosoma mansoni 28-kDa glutathione S-transferase (Sm28GST) protective antigen fused to filamentous hemagglutinin, induces priming in mice for the production of serum antibodies. In addition to significant levels of anti-Sm28GST immunoglobulin A (IgA) antibodies, high levels of anti-Sm28GST serum antibodies were obtained after intranasal boost with the purified antigen or infection with S. mansoni following intranasal priming with BPGR60. These antibodies were of the IgG1, IgG2a, and IgG2b isotypes, suggesting a mixed immune response. No priming was observed in animals that had received nonrecombinant B. pertussis or purified Sm28GST, indicating specific priming by BPGR60. This priming was also evident in immune protection against S. mansoni challenge. Significant protection against worm burden and egg output was obtained in mice primed with BPGR60 and intranasally boosted with purified Sm28GST. A lower but still significant degree of protection against egg output was also obtained in mice infected with a single dose of BPGR60. These results indicate that intranasal administration of recombinant B. pertussis can prime for serum antibody responses against a foreign antigen and for heterologous protection.

This article has been cited by other articles:

• Ho, S. Y., Chua, S. Q., Foo, D. G. W., Locht, C., Chow, V. T., Poh, C. L., Alonso, S. (2008). Highly Attenuated Bordetella pertussis Strain BPZE1 as a Potential Live Vehicle for Delivery of Heterologous Vaccine Candidates. Infect. Immun. 76: 111-119 [Abstract] [Full Text]  
• Alonso, S., Willery, E., Renauld-Mongenie, G., Locht, C. (2005). Production of Nontypeable Haemophilus influenzae HtrA by Recombinant Bordetella pertussis with the Use of Filamentous Hemagglutinin as a Carrier. Infect. Immun. 73: 4295-4301 [Abstract] [Full Text]  
• Grangette, C., Muller-Alouf, H., Hols, P., Goudercourt, D., Delcour, J., Turneer, M., Mercenier, A. (2004). Enhanced Mucosal Delivery of Antigen with Cell Wall Mutants of Lactic Acid Bacteria. Infect. Immun. 72: 2731-2737 [Abstract] [Full Text]  
• Avall-Jaaskelainen, S., Kyla-Nikkila, K., Kahala, M., Miikkulainen-Lahti, T., Palva, A. (2002). Surface Display of Foreign Epitopes on the Lactobacillus brevis S-Layer. Appl. Environ. Microbiol. 68: 5943-5951 [Abstract] [Full Text]  
• Coppens, I., Alonso, S., Antoine, R., Jacob-Dubuisson, F., Renauld-Mongenie, G., Jacobs, E., Locht, C. (2001). Production of Neisseria meningitidis Transferrin-Binding Protein B by Recombinant Bordetella pertussis. Infect. Immun. 69: 5440-5446 [Abstract] [Full Text]  
• Grangette, C., Muller-Alouf, H., Goudercourt, D., Geoffroy, M.-C., Turneer, M., Mercenier, A. (2001). Mucosal Immune Responses and Protection against Tetanus Toxin after Intranasal Immunization with Recombinant Lactobacillus plantarum. Infect. Immun. 69: 1547-1553 [Abstract] [Full Text]  
• Mielcarek, N., Nordstrom, I., Menozzi, F. D., Locht, C., Holmgren, J. (2000). Genital Antibody Responses in Mice after Intranasal Infection with an Attenuated Candidate Vector Strain of Bordetella pertussis. Infect. Immun. 68: 485-491 [Abstract] [Full Text]  
• Sun, J.-B., Mielcarek, N., Lakew, M., Grzych, J.-M., Capron, A., Holmgren, J., Czerkinsky, C. (1999). Intranasal Administration of a Schistosoma mansoni Glutathione S-Transferase-Cholera Toxoid Conjugate Vaccine Evokes Antiparasitic and Antipathological Immunity in Mice. J. Immunol. 163: 1045-1052 [Abstract] [Full Text]  
• Baras, B., Benoit, M.-A., Dupre, L., Poulain-Godefroy, O., Schacht, A.-M., Capron, A., Gillard, J., Riveau, G. (1999). Single-Dose Mucosal Immunization with Biodegradable Microparticles Containing a Schistosoma mansoni Antigen. Infect. Immun. 67: 2643-2648 [Abstract] [Full Text]  
• Kremer, L., Dupre, L., Riveau, G., Capron, A., Locht, C. (1998). Systemic and Mucosal Immune Responses after Intranasal Administration of Recombinant Mycobacterium bovis Bacillus Calmette-Guerin Expressing Glutathione S-Transferase from Schistosoma haematobium. Infect. Immun. 66: 5669-5676 [Abstract] [Full Text]